Efficacy and Safety of Glecaprevir/Pibrentasvir for Chronic Hepatitis C Patients: A Systematic Review and Meta-analysis

Background and Aims: Glecaprevir/pibrentasvir is a pangenotypic regimen recently approved for the treatment of chronic hepatitis C virus (HCV) infection. The objective of the present review was to summarize the findings from clinical trials to understand how patient-related factors influence glecapr...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Hong-Qin, Wang, Chun-Guang, Xiao, Peng, Gao, Yan-Hang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562797/
https://www.ncbi.nlm.nih.gov/pubmed/33083249
http://dx.doi.org/10.14218/JCTH.2020.00047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562797/
https://www.ncbi.nlm.nih.gov/pubmed/33083249
http://dx.doi.org/10.14218/JCTH.2020.00047

Ejemplares similares